Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Yves Cahn

Showing results (71-80 of 168) with videos related to

Pageof 17
Sort By:
Blood|January 15, 2015
Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemiaNathalie Dhédin, Anne Huynh, Sébastien Maury, et al.
Blood|August 30, 2003
Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumorsDidier Blaise, Jacques Olivier Bay, Catherine Faucher, et al.
European Journal of Haematology|January 26, 2017
Impact of body-surface area on patients' outcome in younger adults with acute myeloid leukemiaXavier Cahu, Martin Carré, Christian Recher, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 17, 2002
Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: comparative toxicity and outcomesDaniel Weisdorf, Michael Bishop, Bernie Dharan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2017
Randomized Phase II Study of Clofarabine-Based Consolidation for Younger Adults With Acute Myeloid Leukemia in First RemissionXavier Thomas, Stéphane de Botton, Sylvie Chevret, et al.
Haematologica|August 27, 2013
Prognostic impact of day 15 blast clearance in risk-adapted remission induction chemotherapy for younger patients with acute myeloid leukemia: long-term results of the multicenter prospective LAM-2001 trial by the GOELAMS study groupSarah Bertoli, Pierre Bories, Marie C Béné, et al.
Haematologica|April 9, 2016
Unrelated alternative donor transplantation for severe acquired aplastic anemia: a study from the French Society of Bone Marrow Transplantation and Cell Therapies and the EBMT Severe Aplastic Anemia Working PartyRaynier Devillier, Jean-Hugues Dalle, Austin Kulasekararaj, et al.
The New England Journal of Medicine|September 15, 2016
Rituximab in B-Lineage Adult Acute Lymphoblastic LeukemiaSébastien Maury, Sylvie Chevret, Xavier Thomas, et al.
European Journal of Haematology|March 18, 2021
Conventional chemotherapy for acute myeloid leukemia in older adults: Impact on nutritional, cognitive, and functional statusClaire Jouzier, Jean-François Hamel, Pierre-Yves Dumas, et al.
Bone Marrow Transplantation|October 31, 2019
Influence of alternative donor type on early survival after hematopoietic stem cell transplantation for acute myeloid leukemia lacking a sibling donorClémence Deteix, Florence Mesnil, Sabine Furst, et al.
Pageof 17

Showing results (71-80 of 168) with videos related to

Sort By:
Pageof 17
Blood|January 15, 2015
Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemiaNathalie Dhédin, Anne Huynh, Sébastien Maury, et al.
Blood|August 30, 2003
Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumorsDidier Blaise, Jacques Olivier Bay, Catherine Faucher, et al.
European Journal of Haematology|January 26, 2017
Impact of body-surface area on patients' outcome in younger adults with acute myeloid leukemiaXavier Cahu, Martin Carré, Christian Recher, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 17, 2002
Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: comparative toxicity and outcomesDaniel Weisdorf, Michael Bishop, Bernie Dharan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2017
Randomized Phase II Study of Clofarabine-Based Consolidation for Younger Adults With Acute Myeloid Leukemia in First RemissionXavier Thomas, Stéphane de Botton, Sylvie Chevret, et al.
Haematologica|August 27, 2013
Prognostic impact of day 15 blast clearance in risk-adapted remission induction chemotherapy for younger patients with acute myeloid leukemia: long-term results of the multicenter prospective LAM-2001 trial by the GOELAMS study groupSarah Bertoli, Pierre Bories, Marie C Béné, et al.
Haematologica|April 9, 2016
Unrelated alternative donor transplantation for severe acquired aplastic anemia: a study from the French Society of Bone Marrow Transplantation and Cell Therapies and the EBMT Severe Aplastic Anemia Working PartyRaynier Devillier, Jean-Hugues Dalle, Austin Kulasekararaj, et al.
The New England Journal of Medicine|September 15, 2016
Rituximab in B-Lineage Adult Acute Lymphoblastic LeukemiaSébastien Maury, Sylvie Chevret, Xavier Thomas, et al.
European Journal of Haematology|March 18, 2021
Conventional chemotherapy for acute myeloid leukemia in older adults: Impact on nutritional, cognitive, and functional statusClaire Jouzier, Jean-François Hamel, Pierre-Yves Dumas, et al.
Bone Marrow Transplantation|October 31, 2019
Influence of alternative donor type on early survival after hematopoietic stem cell transplantation for acute myeloid leukemia lacking a sibling donorClémence Deteix, Florence Mesnil, Sabine Furst, et al.
Pageof 17